Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.
about
Prostatic carcinoma: a multivariate analysis of prognostic factors.The expression and localisation of beta-nerve growth factor (beta-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation.TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue.Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.Increase of serum prostatic specific antigen and clinical progression in pN + MO prostate cancer.Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologiesThe effect of androgen deprivation on malignant and benign prostate tissue.Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.A rare case of large cell neuroendocrine carcinoma.Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology.Interferon-alpha prevents selection of doxorubicin-resistant undifferentiated-androgen-insensitive metastatic human prostate cancer cells.Amplification of the androgen receptor gene is associated with P53 mutation in hormone-refractory recurrent prostate cancer.
P2860
Q35978450-C336C76D-94E9-40D4-8967-FC814987DC1DQ36136327-EF335C7D-028B-4E8E-A05D-08D0F66E714CQ38480443-A9722CDA-372C-4706-8E2C-B04E88CD0CE2Q40394596-20E866BB-3C89-4C02-B270-F12087D8DA2DQ40990865-6FF293B9-DA04-4C78-B697-4DCAFEA22C56Q41839859-54F7F1FC-617C-4E6F-BF1E-FBD1F27F8E72Q42450934-BB770E51-3F79-4459-A02A-45884336F619Q42470311-8C2E3790-AD9D-460D-914E-DC22D53442C5Q42959288-A1FEE5B5-0154-4458-B8A2-692098430497Q44168590-95D74E92-E8B4-4DDD-8171-915B68114E20Q53395881-00B42522-270A-4829-82F2-EEC061CE9C8CQ54191855-B503704D-B1A0-45A7-BFF7-4F67846178A2
P2860
Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Hormone resistant prostatic ad ...... and post-treatment specimens.
@ast
Hormone resistant prostatic ad ...... and post-treatment specimens.
@en
type
label
Hormone resistant prostatic ad ...... and post-treatment specimens.
@ast
Hormone resistant prostatic ad ...... and post-treatment specimens.
@en
prefLabel
Hormone resistant prostatic ad ...... and post-treatment specimens.
@ast
Hormone resistant prostatic ad ...... and post-treatment specimens.
@en
P2093
P2860
P356
P1476
Hormone resistant prostatic ad ...... and post-treatment specimens.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1993.344
P407
P577
1993-08-01T00:00:00Z